Clinical Trial Update: Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral minoxidil 1 mg for female androgenetic alopecia is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia

Drugs mentioned

• Oral Minoxidil (minoxidil)

Snippet

Sponsor: Industrial Farmacéutica Cantabria, S.A. | Conditions: Androgenetic Alopecia, Female Pattern Baldness | Phase 3 | Status: NOT_YET_RECRUITING